levodopa has been researched along with Central Nervous System Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Freitas, RM; dos Santos Souza, MP; Fricke, D; Rieder, CR | 1 |
| Kaufmann, H | 1 |
| Masturzo, P; Murialdo, G; Nappi, G; Polleri, A; Sances, G; Savoldi, F | 1 |
| Boulton, AA; Juorio, AV; Li, XM; Paterson, IA | 1 |
| Chokroverty, S; Masdeu, JC; Sander, HW; Tavoulareas, G; Walters, A; Zimmerman, T | 1 |
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Gilbert, JC | 1 |
| Laplane, D | 1 |
| Mawdsley, C | 1 |
| Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ | 1 |
| Astarloa, R; García de Yébenes, J; Mena, M | 1 |
| Balsamo, A; Cacciari, E; Cau, M; Cicognani, A; Paolucci, G; Pirazzoli, P; Rosito, P; Tosi, MT; Vecchi, V | 1 |
| Kameyama, M; Kato, T | 1 |
| Feldman, RG; Lannon, MC | 1 |
3 review(s) available for levodopa and Central Nervous System Disease
| Article | Year |
|---|---|
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Norepinephrine; United States | 2008 |
[Physiopathology of dystonia].
Topics: Animals; Basal Ganglia; Brain Stem; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Dystonia; Humans; Levodopa; Metabolism, Inborn Errors; Models, Neurological; Norepinephrine; Rats; Synaptic Transmission | 1991 |
[Therapy of dementia in the aged].
Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Central Nervous System Diseases; Dementia; Humans; Levodopa; Middle Aged; Parasympathomimetics; Psychotropic Drugs; Rats; Synapses | 1985 |
11 other study(ies) available for levodopa and Central Nervous System Disease
| Article | Year |
|---|---|
Superficial siderosis of the central nervous system associated with parkinsonism.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Central Nervous System Diseases; Female; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Siderosis | 2004 |
Neuroendocrinological signs of central neurotransmission disorders.
Topics: Aging; Central Nervous System Diseases; Endocrine System Diseases; Headache; Humans; Levodopa; Neurotransmitter Agents; Nociceptors; Nomifensine; Periodicity; Prolactin | 1983 |
New mechanisms of action of irreversible monoamine oxidase type B inhibitors.
Topics: Brain; Central Nervous System Diseases; Dopamine; Female; Gene Expression; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline | 1993 |
Orthostatic tremor: an electrophysiological analysis.
Topics: Aged; Antiparkinson Agents; Carbidopa; Central Nervous System Diseases; Clonazepam; Drug Combinations; Electroencephalography; Electromyography; Evoked Potentials; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Muscle, Skeletal; Neural Conduction; Posture; Treatment Outcome; Tremor | 1998 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
Diseases of the central nervous system. Pharmacological basis of treatment.
Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Diseases; Cholinesterase Inhibitors; Edrophonium; Epilepsy; Headache; Humans; Levodopa; Methysergide; Migraine Disorders; Myasthenia Gravis; Parkinson Disease; Pyridostigmine Bromide; Serotonin Antagonists | 1975 |
[On some dangerous withdrawals in neurology].
Topics: Anticoagulants; Barbiturates; Central Nervous System Diseases; Humans; Levodopa; Parasympatholytics; Substance Withdrawal Syndrome | 1979 |
Diseases of the central nervous system. Involuntary movements.
Topics: Athetosis; Central Nervous System Diseases; Chorea; Face; Humans; Levodopa; Movement Disorders; Myoclonus; Parkinson Disease; Spasm; Tic Disorders; Torticollis; Tremor | 1975 |
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord | 1992 |
Differential effects of 18- and 24-Gy cranial irradiation on growth rate and growth hormone release in children with prolonged survival after acute lymphocytic leukemia.
Topics: Arginine; Brain; Central Nervous System Diseases; Child; Child, Preschool; Female; Growth; Growth Hormone; Humans; Levodopa; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage | 1988 |
Parkinson disease. Individualizing therapy.
Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1985 |